Wetimicin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameWetimicin
Drug Alias NameAminoglycoside antibiotic (Jiangsu Institute of Microbiology)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Aminoglycoside antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHangzhou Aida Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHangzhou Aida Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A